Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Jan 15, 2019; 11(1): 17-27
Published online Jan 15, 2019. doi: 10.4251/wjgo.v11.i1.17
Published online Jan 15, 2019. doi: 10.4251/wjgo.v11.i1.17
Figure 1 Flowchart of patient inclusion.
Figure 2 Prognostic impact of serum tumor markers.
A: Overall and disease-free survival curves according to preoperative carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) levels; B: Overall and disease-free survival curves according to postoperative CEA and CA19-9 levels. CEA: Carcinoembryonic antigen; CA19-9: Carbohydrate antigen 19-9.
Figure 3 Evaluation of serum tumor markers before and after surgery.
A: Disease-free survival curves according to perioperative changes in carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) levels; B: Effects of postoperative adjuvant chemotherapy on the prognostic impact of the perioperative levels of CEA and CA19-9. CEA: Carcinoembryonic antigen; CA19-9: Carbohydrate antigen 19-9.
Figure 4 Prevalence of the site of initial recurrences.
A: According to preoperative levels. B: According to postoperative levels. *Statistically significant (P < 0.05). CEA: Carcinoembryonic antigen; CA19-9: Carbohydrate antigen 19-9.
- Citation: Suenaga Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer. World J Gastrointest Oncol 2019; 11(1): 17-27
- URL: https://www.wjgnet.com/1948-5204/full/v11/i1/17.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i1.17